Effects of pegylated interferon‐α based therapies on functional cure and the risk of hepatocellular carcinoma development in patients with chronic hepatitis B
出版年份 2019 全文链接
标题
Effects of pegylated interferon‐α based therapies on functional cure and the risk of hepatocellular carcinoma development in patients with chronic hepatitis B
作者
关键词
-
出版物
JOURNAL OF VIRAL HEPATITIS
Volume 26, Issue S1, Pages 5-31
出版商
Wiley
发表日期
2019-08-05
DOI
10.1111/jvh.13150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B
- (2018) H. L. Y. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study
- (2018) M. Sprinzl et al. JOURNAL OF HEPATOLOGY
- Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
- (2018) Chao-Wei Hsu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
- (2018) Sang Hoon Ahn et al. DIGESTIVE DISEASES AND SCIENCES
- Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
- (2018) Peipei Ren et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Global HBV burden: guesstimates and facts
- (2018) Dina Ginzberg et al. Hepatology International
- A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha
- (2017) Zhenhuan Cao et al. HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up
- (2017) F. Stelma et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B surface antigen reduction by switching from long-term nucleoside/nucleotide analogue administration to pegylated interferon
- (2017) N. Tamaki et al. JOURNAL OF VIRAL HEPATITIS
- Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
- (2016) F. Liu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
- (2016) Patrick Marcellin et al. GASTROENTEROLOGY
- Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study
- (2016) Jian Sun et al. JOURNAL OF HEPATOLOGY
- CONSORT
- (2016) Ka Zhang et al. MEDICINE
- An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys)
- (2016) Young Eun Chon et al. MEDICINE
- HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients
- (2016) Song Yang et al. Virology Journal
- Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients
- (2016) Li-Ting He et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis
- (2016) Yin-Chen Wang et al. Scientific Reports
- Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
- (2015) Guo-Jun Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)
- (2015) Willem Pieter Brouwer et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B
- (2015) Kung-Hao Liang et al. JOURNAL OF INFECTIOUS DISEASES
- Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
- (2015) Keiichi Masaki et al. Virology Journal
- A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B
- (2014) Q. Xie et al. CLINICAL INFECTIOUS DISEASES
- Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
- (2014) Qin Ning et al. JOURNAL OF HEPATOLOGY
- Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B
- (2014) Xuefu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Long-term outcome in Caucasian patients with chronic hepatitis B virus infection after HBsAg seroclearance
- (2014) Eugenia Lauret et al. LIVER INTERNATIONAL
- On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
- (2014) Ioannis Goulis et al. LIVER INTERNATIONAL
- Efficacy and safety of peginterferon alfa-2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B
- (2013) Dong Jin Suh et al. ANTIVIRAL THERAPY
- Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir
- (2013) R Bart Takkenberg et al. ANTIVIRAL THERAPY
- The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients
- (2013) Umit B. Dogan et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels
- (2013) Milan J. Sonneveld et al. HEPATOLOGY
- Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs
- (2013) Denis Ouzan et al. JOURNAL OF CLINICAL VIROLOGY
- Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion
- (2013) Zhen Huan Cao et al. Journal of Digestive Diseases
- A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B
- (2012) Paola Piccolo et al. ANTIVIRAL THERAPY
- Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
- (2012) Pietro Lampertico et al. GUT
- Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
- (2012) Patrick Marcellin et al. Hepatology International
- Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
- (2011) Y.-F. Liaw et al. HEPATOLOGY
- Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients
- (2011) Teerha Piratvisuth et al. Hepatology International
- A Randomized Trial of Peginterferon α-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B
- (2010) Vincent Rijckborst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
- (2010) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment
- (2010) Bettina E. Hansen et al. JOURNAL OF MEDICAL VIROLOGY
- Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients
- (2010) R. Moucari et al. JOURNAL OF VIRAL HEPATITIS
- A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
- (2009) Paola Piccolo et al. ANTIVIRAL THERAPY
- Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
- (2009) Erik H.C.J. Buster et al. GASTROENTEROLOGY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis
- (2009) Y.-F. Yang et al. JOURNAL OF VIRAL HEPATITIS
- Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
- (2008) J. J. Y. SUNG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now